EUVIMEDScopri EUVIMED
Übersichtsarbeit

Neuroprotective and anti‐inflammatory effects of curcumin in Alzheimer's disease: Targeting neuroinflammation strategies

Elena Azzini, Sheila I Peña-Corona, Héctor Hernández-Parra, Deepak Chandran, Lejaniya Abdul Kalam Saleena, Yousef Sawikr, Ilaria Peluso, Sangram Dhumal, Manoj Kumar, Gerardo Leyva-Gómez, Miquel Martorell, Javad Sharifi-Rad iD and 1 more

Phytotherapy Research · 2024-06 · 38 (6) · 3169-3189

DOI: 10.1002/ptr.8200 ↗

At a glance

Übersichtsarbeit in Phytotherapy Research, published online on 2024-04-14. Written by Elena Azzini and 12 co-authors. Institution: Research Centre for Food and Nutrition, Council for Agricultural Research and Economics (CREA-AN), Rome, Italy. Major MEDLINE topics: Curcumin, Alzheimer Disease, Neuroprotective Agents, Anti-Inflammatory Agents. Cited 116 times so far (Crossref); 159 references.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by the accumulation of amyloid‐beta plaques and neurofibrillary tangles, leading to neuronal loss. Curcumin, a polyphenolic compound derived from Curcuma longa , has shown potential neuroprotective effects due to its anti‐inflammatory and antioxidant properties. This review aims to synthesize current preclinical data on the anti‐neuroinflammatory mechanisms of curcumin in the context of AD, addressing its pharmacokinetics, bioavailability, and potential as a therapeutic adjunct. An exhaustive literature search was conducted, focusing on recent studies within the last 10 years related to curcumin's impact on neuroinflammation and its neuroprotective role in AD. The review methodology included sourcing articles from specialized databases using specific medical subject headings terms to ensure precision and relevance. Curcumin demonstrates significant neuroprotective properties by modulating neuroinflammatory pathways, scavenging reactive oxygen species, and inhibiting the production of pro‐inflammatory cytokines. Despite its potential, challenges remain regarding its limited bioavailability and the scarcity of comprehensive human clinical trials. Curcumin emerges as a promising therapeutic adjunct in AD due to its multimodal neuroprotective benefits. However, further research is required to overcome challenges related to bioavailability and to establish effective dosing regimens in human subjects. Developing novel delivery systems and formulations may enhance curcumin's therapeutic potential in AD treatment.

Subjects

MeSH terms (MEDLINE)

CurcuminAlzheimer DiseaseNeuroprotective AgentsAnti-Inflammatory AgentsHumansAnimalsNeuroinflammatory DiseasesAntioxidantsCurcumaBiological Availability

Author keywords

Alzheimer's diseaseamyloid‐betaanti‐inflammatory agentsblood–brain barriercurcuminneuroinflammationneuroprotectionoxidative stress

Substances

CurcuminNeuroprotective AgentsAnti-Inflammatory AgentsAntioxidants

Authors and institutions

  • Research Centre for Food and Nutrition, Council for Agricultural Research and Economics (CREA-AN), Rome, Italy.
  • Departamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.
  • Department of Veterinary Sciences and Animal Husbandry, Amrita School of Agricultural Sciences, Amrita Vishwa Vidyapeetham University, Coimbatore, India.
  • Department of Food Science and Nutrition, Faculty of Applied Sciences, UCSI University, Kuala Lumpur, Malaysia.
  • Department of Pharmacology and Toxicology, Faculty of Medicine University of Ajdabiya, Ajdabiya, Libya.
  • Division of Horticulture, RCSM College of Agriculture, Kolhapur, India.

ORCID profiles: Javad Sharifi-Rad, Daniela Calina

Cite

APA

Azzini, E., Peña-Corona, S. I., Hernández-Parra, H., Chandran, D., Saleena, L. A. K., Sawikr, Y., Peluso, I., Dhumal, S., Kumar, M., Leyva-Gómez, G., Martorell, M., Sharifi-Rad, J., & Calina, D. (2024). Neuroprotective and anti‐inflammatory effects of curcumin in Alzheimer's disease: Targeting neuroinflammation strategies. Phytotherapy Research, 38(6), 3169-3189. https://doi.org/10.1002/ptr.8200

Vancouver

Azzini E, Peña-Corona SI, Hernández-Parra H, Chandran D, Saleena LAK, Sawikr Y, et al. Neuroprotective and anti‐inflammatory effects of curcumin in Alzheimer's disease: Targeting neuroinflammation strategies. Phytotherapy Research. 2024;38(6):3169-3189. doi:10.1002/ptr.8200

BibTeX
@article{Azzini2024,
  author = {Azzini, Elena and Peña-Corona, Sheila I and Hernández-Parra, Héctor and Chandran, Deepak and Saleena, Lejaniya Abdul Kalam and Sawikr, Yousef and Peluso, Ilaria and Dhumal, Sangram and Kumar, Manoj and Leyva-Gómez, Gerardo and Martorell, Miquel and Sharifi-Rad, Javad and Calina, Daniela},
  title = {Neuroprotective and anti‐inflammatory effects of curcumin in Alzheimer's disease: Targeting neuroinflammation strategies},
  journal = {Phytotherapy Research},
  year = {2024},
  volume = {38},
  number = {6},
  pages = {3169--3189},
  doi = {10.1002/ptr.8200}
}
Start for free →